Meanwhile, HADHA mRNA was related to better OS in stage I (HR 95% CI=0.44 (0.24-0.82)) and IV (HR 95% CI=0.37 (0.21-0.61)) ccRCC patients. This evidence concerns the gene HADHA and nonpapillary renal cell carcinoma.